SRSF2 and acute myeloid leukemia: A study to examine the expression levels of these CSF3R mRNA variants in patients with AML found that those harboring SRSF2 mutations and SRSF2 knock-out cells both exhibit a significant alteration in the V3/V1 ratio, suggesting SRSF2-mediated CSF3R splicing 16.